Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Rigel Pharmaceuticals
AstraZeneca
Air Liquide Santé International
GT Medical Technologies, Inc.
GT Medical Technologies, Inc.
RECORDATI GROUP
Pfizer
Danone Specialized Nutrition
Hoffmann-La Roche
Novartis
Takeda
Pfizer
Hoffmann-La Roche
Hoffmann-La Roche
Taiwan Mundipharma Pharmaceuticals Ltd.
Taiwan Mundipharma Pharmaceuticals Ltd.
Jiangsu Famous Medical Technology Co., Ltd.
Dr. Reddy's Laboratories Limited
Celgene
Pfizer
Novartis
VIFORFRANCE
Merck Sharp & Dohme LLC
Mundipharma Korea Ltd
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Novartis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
Novartis
Merit Medical Systems, Inc.
Ortho Biotech Products, L.P.
Mundipharma Korea Ltd
Mallinckrodt
Mundipharma Korea Ltd
GlaxoSmithKline
Pharmatech
CSA Medical, Inc.
Bayer
Janssen-Cilag Ltd.
Cttq
Janssen-Cilag Ltd.,Thailand
Janssen Pharmaceutica
Janssen Korea, Ltd., Korea
Sanofi
ActiViews Ltd.
ActiViews Ltd.
GlaxoSmithKline